First Light Asset Management, LLC
Edina, MN · CIK 1600004 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2013 · limited liability company
- Assets managed$1.4bn
- Staff14 · 7 in investment roles
- Main clients (by assets)Private funds 69%, High net worth individuals 25%, Individuals 3%
- Private funds3 (3 hedge) · $975.2m gross assets
- Form ADV · 2026-03-24SEC adviser record
- Legal entityFIRST LIGHT ASSET MANAGEMENT, LLC (US)
$1.6bn
reported value
+47.4% vs Q1 2026
31positions
60.7%in top 10
2 new
17 added
12 reduced
6 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| NEOGENOMICS INC NEO | $179.2m10.89% | Added +2.5m |
| SI-BONE INC SIBN | $132.6m8.06% | Added +2.8m |
| AXOGEN INC AXGN | $126.9m7.72% | Reduced -1.3m |
| APOGEE THERAPEUTICS INC COM | $123.5m7.50% | Added +353.6k |
| PALVELLA THERAPEUTICS INC NE PVLA | $118.0m7.17% | Reduced -208.9k |
| TWIST BIOSCIENCE CORP TWST | $74.9m4.55% | Reduced -150.9k |
| ENLIVEN THERAPEUTICS INC ELVN | $69.1m4.20% | Added +1.2m |
| GUARDANT HEALTH INC GH | $66.3m4.03% | Added +161.3k |
| 908 DEVICES INC MASS | $54.7m3.32% | Added +210.2k |
| AMYLYX PHARMACEUTICALS INC AMLX | $54.3m3.30% | Reduced -167.4k |
| GENEDX HOLDINGS CORP WGS | $53.8m3.27% | Added +541.0k |
| SIMULATIONS PLUS INC COM | $51.1m3.11% | Added +159.9k |
| TANDEM DIABETES CARE INC TNDM | $51.1m3.10% | Added +2.1m |
| CRINETICS PHARMACEUTICALS IN CRNX | $50.9m3.10% | Added +271.2k |
| NEUROPACE INC NPCE | $45.5m2.76% | Added +401.2k |
| EDGEWISE THERAPEUTICS INC EWTX | $44.5m2.70% | Added +93.3k |
| ANAPTYSBIO INC ANAB | $39.3m2.39% | Added +16.6k |
| TREVI THERAPEUTICS INC TRVI | $39.1m2.38% | New |
| SEPTERNA INC SEPN | $32.3m1.96% | Added +230.4k |
| TRISALUS LIFE SCIENCES INC TLSI | $29.8m1.81% | Added +1.5m |
| TECTONIC THERAPEUTIC INC TECX | $27.5m1.67% | Added +153.0k |
| HEALTH CATALYST INC HCAT | $25.5m1.55% | Reduced -67.8k |
| BUTTERFLY NETWORK INC BFLY | $22.2m1.35% | Reduced -17.8k |
| ESTABLISHMENT LABS HLDGS INC ESTA | $21.2m1.29% | Reduced -61.2k |
| VAXCYTE INC PCVX | $20.1m1.22% | Added +203.4k |
| IRHYTHM TECHNOLOGIES INC IRTC | $19.9m1.21% | Reduced -1.0k |
| OMNICELL COM OMCL | $18.8m1.14% | Reduced -37.5k |
| ATRICURE INC ATRC | $15.9m0.97% | Reduced -161.7k |
| KORU MEDICAL SYSTEMS INC KRMD | $14.2m0.86% | Reduced -380.5k |
| TACTILE SYS TECHNOLOGY INC TCMD | $13.8m0.84% | New |
| RHYTHM PHARMACEUTICALS INC RYTM | $9.5m0.58% | Reduced -1.4k |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| CENTESSA PHARMACEUTICALS PLC | $62.0m1.6m shares |
| WAVE LIFE SCIENCES LTD 96663EUR | $13.4m1.8m shares |
| VERA THERAPEUTICS INC VERA | $12.6m313.9k shares |
| MIMEDX GROUP INC MDXG | $11.2m2.8m shares |
| SPYGLASS PHARMA INC SGP | $9.7m375.0k shares |
| ORGANOGENESIS HLDGS INC ORGO | $8.3m3.5m shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| SI-BONE INC SIBN · 13G · filed 2026-05-07 | 18.4%≈ $132.5m |
| HEALTH CATALYST INC HCAT · 13D · filed 2026-03-13 | 18.3%≈ $26.8m |
| 908 DEVICES INC MASS · 13G · filed 2026-02-17 | 17.1%≈ $53.8m |
| PERFORMANT HEALTHCARE INC PFMT · 13G · filed 2025-08-14 | 16.4% |
| SIMULATIONS PLUS INC 13G · filed 2026-02-06 | 13.2%≈ $48.5m |
| NEUROPACE INC NPCE · 13G · filed 2026-09-04 | 12.2%≈ $66.8m |
| TRISALUS LIFE SCIENCES INC TLSI · 13G · filed 2026-07-07 | 10.7%≈ $30.0m |
| NEOGENOMICS INC NEO · 13G · filed 2026-08-14 | 8.4%≈ $157.0m |
| KORU MEDICAL SYSTEMS INC KRMD · 13G · filed 2026-02-17 | 8.3%≈ $16.1m |
| AXOGEN INC AXGN · 13G · filed 2026-08-14 | 7.6%≈ $188.1m |
| PALVELLA THERAPEUTICS INC NE PVLA · 13G · filed 2026-08-14 | 5.3%≈ $117.5m |